S&P 500   3,113.21 (+0.01%)
DOW   27,651.26 (+0.01%)
QQQ   202.43 (+0.00%)
AAPL   265.01 (+1.25%)
FB   198.61 (-0.05%)
MSFT   149.78 (-0.05%)
GOOGL   1,318.88 (+0.00%)
AMZN   1,745.92 (-0.84%)
CGC   18.53 (+0.82%)
NVDA   208.39 (-0.49%)
MU   46.44 (+0.30%)
BABA   199.77 (+3.11%)
TSLA   331.27 (-0.53%)
T   38.28 (+0.45%)
AMD   39.73 (+0.10%)
PRI   134.68 (+1.12%)
NFLX   299.98 (-1.43%)
BAC   33.10 (-0.15%)
GILD   65.98 (-1.15%)
DIS   148.17 (-0.07%)
S&P 500   3,113.21 (+0.01%)
DOW   27,651.26 (+0.01%)
QQQ   202.43 (+0.00%)
AAPL   265.01 (+1.25%)
FB   198.61 (-0.05%)
MSFT   149.78 (-0.05%)
GOOGL   1,318.88 (+0.00%)
AMZN   1,745.92 (-0.84%)
CGC   18.53 (+0.82%)
NVDA   208.39 (-0.49%)
MU   46.44 (+0.30%)
BABA   199.77 (+3.11%)
TSLA   331.27 (-0.53%)
T   38.28 (+0.45%)
AMD   39.73 (+0.10%)
PRI   134.68 (+1.12%)
NFLX   299.98 (-1.43%)
BAC   33.10 (-0.15%)
GILD   65.98 (-1.15%)
DIS   148.17 (-0.07%)
S&P 500   3,113.21 (+0.01%)
DOW   27,651.26 (+0.01%)
QQQ   202.43 (+0.00%)
AAPL   265.01 (+1.25%)
FB   198.61 (-0.05%)
MSFT   149.78 (-0.05%)
GOOGL   1,318.88 (+0.00%)
AMZN   1,745.92 (-0.84%)
CGC   18.53 (+0.82%)
NVDA   208.39 (-0.49%)
MU   46.44 (+0.30%)
BABA   199.77 (+3.11%)
TSLA   331.27 (-0.53%)
T   38.28 (+0.45%)
AMD   39.73 (+0.10%)
PRI   134.68 (+1.12%)
NFLX   299.98 (-1.43%)
BAC   33.10 (-0.15%)
GILD   65.98 (-1.15%)
DIS   148.17 (-0.07%)
S&P 500   3,113.21 (+0.01%)
DOW   27,651.26 (+0.01%)
QQQ   202.43 (+0.00%)
AAPL   265.01 (+1.25%)
FB   198.61 (-0.05%)
MSFT   149.78 (-0.05%)
GOOGL   1,318.88 (+0.00%)
AMZN   1,745.92 (-0.84%)
CGC   18.53 (+0.82%)
NVDA   208.39 (-0.49%)
MU   46.44 (+0.30%)
BABA   199.77 (+3.11%)
TSLA   331.27 (-0.53%)
T   38.28 (+0.45%)
AMD   39.73 (+0.10%)
PRI   134.68 (+1.12%)
NFLX   299.98 (-1.43%)
BAC   33.10 (-0.15%)
GILD   65.98 (-1.15%)
DIS   148.17 (-0.07%)
Log in

LON:VRP - Verona Pharma Share Price, Forecast & News

GBX 43.50
0.00 (0.00 %)
(As of 12/5/2019 01:47 PM ET)
Today's Range
42
Now: GBX 43.50
43.35
50-Day Range
39.60
MA: GBX 45.31
49.50
52-Week Range
39.60
Now: GBX 43.50
106.20
Volume11,028 shs
Average Volume49,797 shs
Market Capitalization£45.82 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-32834200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowGBX 39 per share
Book ValueGBX 38.20 per share

Profitability

Miscellaneous

Employees22
Market Cap£45.82 million
Next Earnings DateN/A
OptionableOptionable

Receive VRP News and Ratings via Email

Sign-up to receive the latest news and ratings for VRP and its competitors with MarketBeat's FREE daily newsletter.


Verona Pharma (LON:VRP) Frequently Asked Questions

What is Verona Pharma's stock symbol?

Verona Pharma trades on the London Stock Exchange (LON) under the ticker symbol "VRP."

How were Verona Pharma's earnings last quarter?

Verona Pharma Plc (LON:VRP) posted its quarterly earnings results on Tuesday, August, 6th. The company reported ($13.65) earnings per share for the quarter. View Verona Pharma's Earnings History.

What is the consensus analysts' recommendation for Verona Pharma?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Verona Pharma in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Verona Pharma.

Has Verona Pharma been receiving favorable news coverage?

News stories about VRP stock have been trending somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Verona Pharma earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Verona Pharma.

Who are some of Verona Pharma's key competitors?

What other stocks do shareholders of Verona Pharma own?

Who are Verona Pharma's key executives?

Verona Pharma's management team includes the folowing people:
  • Dr. Jan-Anders Karlsson, CEO & Exec. Director (Age 64)
  • Mr. Piers John Morgan, Chief Financial Officer (Age 53)
  • Ms. Claire Louise Poll L.C.S.W., B.A., B Juris, LLB, ASIA, Gen. Counsel (Age 52)
  • Ms. Victoria Stewart, Director of Communications
  • Dr. Peter Spargo, Sr. VP of Chemistry Manufacturing & Controls (Age 57)

How do I buy shares of Verona Pharma?

Shares of VRP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Verona Pharma's stock price today?

One share of VRP stock can currently be purchased for approximately GBX 43.50.

How big of a company is Verona Pharma?

Verona Pharma has a market capitalization of £45.82 million. Verona Pharma employs 22 workers across the globe.View Additional Information About Verona Pharma.

What is Verona Pharma's official website?

The official website for Verona Pharma is http://www.veronapharma.com/.

How can I contact Verona Pharma?

Verona Pharma's mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The company can be reached via phone at +44-20-32834200.


MarketBeat Community Rating for Verona Pharma (LON VRP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  211 (Vote Outperform)
Underperform Votes:  222 (Vote Underperform)
Total Votes:  433
MarketBeat's community ratings are surveys of what our community members think about Verona Pharma and other stocks. Vote "Outperform" if you believe VRP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel